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Understanding Modern Vaccines:
Perspectives in VaccinologyPrefaceMiss Jennings dies, the third nurse to
make supreme sacriﬁce
“Miss Jennings, a nurse, died at the Glendale hospital
Thursday evening at 6 o’clock. Miss Jennings took sick with
inﬂuenza several days ago and grew worse until the end
came last evening. She was 22 years of age and was in her
second year of training. This is the third nurse that has died
at the hospital this week of inﬂuenza. They paid the
supreme sacriﬁce while caring for the sick of the community.
Each girl worked as long as she could be on her feet,
regardless of her own feelings. Miss Wright, another nurse,
is not expected to survive the day, of inﬂuenza.”
Moundsville [West Virginia] Weekly Echo e 6 December 1918For most of our history, humans could do little to protect themselves
against infectious diseases as dramatically illustrated by the
inﬂuenza pandemic of 1918e1919. However, over the past four
centuries vaccines have had an immeasurable impact on 2011 Elsevier B.V.
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viii PREFACEhuman health. In the 18th century the development of the vaccinia
virus vaccine provided a safe approach to protect against the
deadly scourge of smallpox. In the 19th century fundamental
discoveries in microbiology and immunology led to a basic
understanding of how vaccines protect against infectious diseases.
Work by Louis Pasteur, Émile Roux and others showed that
vaccines containing inactivated or attenuated microbes could
protect against ancient afﬂictions like rabies, cholera and typhoid.
The pace of scientiﬁc innovation accelerated in the 20th century in
parallel with the development of new vaccines. Novel methods for
producing vaccine antigens, including cell culture systems and
genetic engineering, were invented and new ways of enhancing
vaccine potency, including adjuvants and carrier protein
conjugation, were discovered. Between 1913 and 1997, new
vaccines for 20 diseases became available that provided defence
against feared childhood diseases, such as diphtheria, pertussis,
measles and Haemophilus inﬂuenzae type b infection, and other
worldwide killers, including inﬂuenza, polio and hepatitis B virus.
In the ﬁrst decade of the 21st century alone, 10 new vaccines
have been licensed including the ﬁrst therapeutic vaccine for a
viral infection (herpes zoster), the ﬁrst adjuvanted prophylactic
cancer vaccines (human papillomavirus), the ﬁrst therapeutic
cancer vaccine (prostate cancer), and the ﬁrst intranasal
vaccine (inﬂuenza).
New technologies, new discoveries and greater understanding
of human immunology and microbial pathogenesis will continue
to facilitate the development of new and improved vaccines.
The ﬁeld of vaccine research and development has grown
increasingly sophisticated and complex. This new textbook,
written by internationally recognised vaccine experts, provides a
comprehensive overview of the essential aspects of vaccine
development. The six chapters of this book examine the fascinating
history of vaccine development, provide a comprehensible review
of vaccine immunology, elucidate the science of vaccine antigens
and vaccine adjuvants, clarify the complex vaccine development
pathway from concept to testing to licensure and implementation,
PREFACE ixand ﬁnally the book explores the near future describing the exciting
developments that promise to deliver new vaccines for known and
yet to be discovered targets as well as vaccines for non-traditional
targets such as autoimmune diseases, malignancies and addiction.
The editors would like to acknowledge the generations of vaccine
researchers whose determination, commitment and brilliance have
made the world a better and safer place.
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